Europe At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies) Industry Trends and Forecast to 2029.
Europe At-Home Testing Kits Analysis and Insights
Europe at-home testing kits market is expected to grow as earlier, people used to visit hospitals often, even for basic problems, but due to the rising awareness regarding several products, this behavior has changed and has turned the trend. At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.
This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription which can easily drive the Europe at-home testing kits market. At-home testing kits allow end-users to collect their specimen at home and then either perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test or HIV, or any other infectious diseases test.
These at home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results that has become a restraint for the Europe at-home testing kits market. However, a false positive result of a test may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19, which can be performed at home. But there are various accuracy-related issues due to which the distribution of those at-home test kits that has been suspended from verifying their reliability.
Data Bridge Market Research analyzes that the Europe at-home testing kits market will grow at a CAGR of 5.9% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019-2014)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)
|
|
Countries Covered
|
Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium and Rest of Europe
|
|
Market Players Covered
|
Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, BD, Drägerwerk AG & Co. KGaA, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG., Nectar Lifesciences Ltd. (Rapikit), ACON Laboratories, Inc., Quidel Corporation., ARKRAY USA, Inc., BTNX INC., Atomo Diagnostics, Eurofins Scientific, Piramal Enterprises Ltd., Bionime Corporation., Nova Biomedical, Cardinal Health., OraSure Technologies, Biolytical Laboratories Inc., Everlywell, Inc., SA Scientific Ltd., Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH), Biosynex, PRIMA Lab SA, MP BIOMEDICALS., Sterilab Services, Chembio Diagnostics, Inc., BioSure, Selfdiagnostics OU among others
|
Europe At-Home Testing Kits Market Definition
At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, and infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample.
Europe At-Home Testing Kits Market Dynamics
Drivers
- Growing adoption of self-testing kits
Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor.
This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.
- Easy availability of self-testing kits at pharmacies
At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.
This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.
Opportunity
- Advent of advanced technologies
The latest technologies are crucial in making medical products very advanced and reliable to trust. In different medical devices, Artificial Intelligence (AI) and Machine Learning (ML) are important aspects of the healthcare sector with the ability to enhance patient safety and administrative processes by work automation and quicker performance.
It is certain that, by default, AI-powered diagnostic instruments will continue to develop. AI has only taken modest moves into a huge and multi-dimensional opportunity in the healthcare sector.
Restraint/Challenge
- Inaccuracy of results by self-testing kits
At-home testing kits allow end-users to collect their specimen at home and perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test, HIV test, or any other infectious diseases test.
These at-home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results. COVID-19 home monitoring can be more comfortable than going to a hospital or doctor's office. It will also help reduce the risk of the coronavirus being spread or acquired when you are screened.
However, a false positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19 which can be performed at home, but there are various accuracy-related issues due to which the distribution of those at-home test kits has been suspended from verifying their reliability.
Post COVID-19 Impact on Europe At-Home Testing Kits Market
COVID-19 created a great impact on the Europe at-home testing kits market. The market for at-home testing kits is expanding as a consequence of the increased popularity of self-help and Do-It-Yourself (DIY) test kits due to their convenience and quick results. Consumers have concerns about the dependability of rapid home testing kits, which could impede the market's expansion for at-home testing kits. Rapid testing kits for COVID-19 are now urgently needed by companies in order to reduce patient deaths and boost patient recovery rates and also increased rate for the at home testing kits market for Diabetic patients and patients having heart problems. This is creating a major market opportunity for at-home testing kits.
Recent Development
- In April 2022, Ascensia Diabetes Care, a global diabetes care company, announces that it has launched the next-generation Eversense E3 Continuous Glucose Monitoring (CGM) System for patients in the U.S., alongside the new Eversense PASS savings program. Eversense E3, which is developed by Senseonics Holdings, Inc. was approved for use up to 6 months by the U.S. Food and Drug Administration (FDA) earlier this year, making it the longest lasting CGM sensor available in the U.S. This has helped company to expand their product portfolio in the market.
Europe At-Home Testing Kits Market Scope
Europe at-home testing kits market is categorized into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Pregnancy Test
- HIV Test Kit
- Diabetes
- Infectious Diseases
- Glucose Tests
- Ovulation Predictor Test Kit
- Drug Abuse Test Kit
- Others
Based on test type, the Europe at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others.
Type
- Cassette
- Strip
- Midstream
- Test Panel
- Dip Card
- Others
Based on type, the Europe at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others.
Age
- Pediatric
- Adult
- Geriatric
Based on age, the Europe at-home testing kits market is segmented into pediatric, adult, and geriatric.
Sample Type
- Urine
- Blood
- Saliva
- Others
Based on sample type, the Europe at-home testing kits market is segmented into urine, blood, saliva, and others.
Usage
- Disposable
- Reusable
Based on usage, the Europe at-home testing kits market is segmented into disposable and reusable.
Distribution Channels
- Retail Pharmacies
- Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
Based on distribution channels, the Europe at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies.
Europe At-Home Testing Kits Market Regional Analysis/Insights
Europe at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage, and distribution channels.
The regions covered in the Europe at-home testing kits market report are Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium and Rest of Europe.
Germany dominates the Europe at-home testing kits market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the country's high healthcare expenditure and the increasing awareness about the Europe at-home testing kits market.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe At-Home Testing Kits Market Share Analysis
Europe at-home testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the Europe at-home testing kits market.
Some of the major players operating in the Europe at-home testing kits market are Abbott, ACON Laboratories, Inc., Rapikit, BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., Siemens Healthcare GmbH, Quidel Corporation, Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Nova Biomedical, AdvaCare Pharma, AccuBioTech Co., Ltd., Atlas Medical UK, TaiDoc Technology Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Sensing Self, PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO.,LTD., Mylan N.V. (a subsidiary of Viatris, Inc.), MP BIOMEDICALS, VedaLab, Shanghai Chemtron Biotech Co.Ltd., and Ascensia Diabetes Care Holdings AG among other domestic players.
SKU-